Graham Allaway

All filings by Graham Allaway on record concern Panacos Pharmaceuticals, Inc. The record holds 50 filings, for trades running from 3 January 2006 to 17 December 2007.

In open-market terms, that means 6 purchases worth €29k on one side and 29 sales worth €932k on the other. Taken together, the sales exceed the purchases by €903k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 2 share grants and 13 option exercises. In 2007 alone, the filings show 6 purchases and no sales.

In size, the median ticket on the buying side is €2,803. For 6 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -18.6%. These figures describe past trades and do not predict future prices.

On 18 December 2007 came the latest disclosure, an open-market purchase for €2,803 in Panacos Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.